United States· US:37662-0730_e3281609-460b-4982-e053-2995a90a01c5
Divalproex Sodium
A medicinal product containing valproate sodium, registered in United States by Hahnemann Laboratories, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VALPROATE SODIUM
- Manufacturer
- Hahnemann Laboratories, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1137662-0730-1
- ndc1137662-0730-2
- ndc1137662-0730-3
- ndc1137662-0730-4
- ndc113766207301200 PELLET in 1 VIAL, GLASS (37662-0730-1)
- ndc113766207302500 PELLET in 1 VIAL, GLASS (37662-0730-2)
- ndc1137662073033000 PELLET in 1 BOTTLE, GLASS (37662-0730-3)
- ndc11376620730410000 PELLET in 1 BOTTLE, GLASS (37662-0730-4)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Valproate sodium in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDepakin 200mg/ml oral solutionImported (Italy)
- CzechiaCONVULEXG.L. Pharma GmbH, Lannach
- FinlandAbsenorParanova Oy
- SwedenAbsenor 100 mg EnterotablettOrion Corporation
- GermanyErgenylSanofi-Aventis Deutschland Gmbh
- BelgiumConvulex Retard 300 mgG.L. Pharma
- NorwayDeprakine RetardSanofi-aventis
- PolandAbsenorOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Convulex, Convulex Für Kinder
- Belgium · Depakine, Depakine Enteric
- Bulgaria · Convulex Chrono, Депакин
- Cyprus · Depakine, Epixival
- Czechia · Convulex, Convulex Cr
- Germany · Ergenyl, Ergenyl Intravenös
- Denmark · Delepsine, Delepsine Retard
- Estonia · Convulex, Convulex Retard
- Spain · Ácido Valproico Altan Pharmaceuticals, S.A., Acido Valproico Seacross
- Finland · Absenor, Orfiril
- France · Depakine, L.P.
- United Kingdom (Northern Ireland) · Epilim, Episenta
- Greece · Depakine, Hexaquin
- Croatia · Convyval
- Hungary · Convulex, Convulex Gyermekeknek
- Ireland · Epilim, Epilim Enteric
- Iceland · Orfiril, Orfiril Retard
- Italy · Acido Valproico Sandoz, Depakin
- Lithuania · Convulex, Convulex Retard
- Luxembourg · Depakine, Depakine Enteric
- Latvia · Convulex, Convulex Retard
- Malta · Epilim Liquid
- Netherlands · Depakine Enteric, Depakine I.V.
- Norway · Orfiril, Orfiril Long
- Poland · Absenor, Convival Chrono
- Portugal · Ácido Valpróico Generis, Depakine
- Romania · Depakine, Orfiril Long
- Sweden · Absenor, Absenor Depot
- Slovenia · Convyval
- Slovakia · Convulex, Convulex Cr
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ccc4243-f3ec-4dd1-b5fc-1c38ea572575 GET /v1/drugs/1ccc4243-f3ec-4dd1-b5fc-1c38ea572575?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "VALPROATE SODIUM",
"productndc": "37662-0730",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about valproate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.